Mindray to acquire control of APT Medical for $927M

Mindray announced its intention to acquire control of APT Medical (688617.SH), a Chinese cardiovascular medical device company, for 6.65 billion yuan ($927 million) through a share transfer and voting rights waiver. Mindray will become the largest and controlling shareholder with 24.61% of APT Medical's equity.

“Mindray announced its intention to acquire control of APT Medical (688617.SH), a medical device company listed on the Sci-Tech Innovation Board of Shanghai Stock Exchange, using its own funds of 6.65 billion yuan ($927 million).”mindray.com

• 2 sources
• mindray.comMindray Plans $927 Million Deal to Control APT Medical - MindrayJan 29, 2024
• hospimedica.comMindray to Acquire Chinese Medical Device Company APT Medical - Business - Hospimedica.comFeb 5, 2024

Summarized from public sources; check the original articles before acting on it.